Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Biopharma sues USPTO over rejected shock therapy patent
Biotechnology
Complaint sought judicial validation of the company's patent claims for a distributive shock treatment | Disputes the PTAB's decision deeming the invention obvious.   6 June 2024
Looking back at the UPC’s ‘successful’ first year
article
Court seen as “exceeding expectations” | Experts urge caution, emphasising that confident and reliable court judgments are needed | High-stakes patent litigation, especially in pharmaceuticals, remains predominantly within national courts.   4 June 2024
Delaware court sides with Abbott in glucose monitor dispute with DexCom
Big Pharma
Delaware judge denies DexCom’s motion to dismiss two counter-counterclaims in complex dispute with rival Abbott over glucose monitors | But judge also says Abbott is not entitled to further remedy.   4 June 2024
Careers
ABG IP says the promotions recognise staff performance, improve gender equality and lower the average age among partners, and secure its values and position in the market.   4 June 2024
Medtech
University of British Columbia alleges patent infringement by medtech companies | Suit concerns AI-driven ultrasound systems for cardiac imaging.   30 May 2024
Europe
WIPO member states approve treaty addressing IP issues related to genetic resources and traditional knowledge | Agreement marks new era for IP rights and Indigenous Peoples, introducing international legal requirements for patent applicants.   28 May 2024
Americas
US and Indian firms reach agreement to settle US litigation and UK arbitration | HDT had accused Emcure of trade secrets theft over COVID-19 vaccine technology.   28 May 2024
Big Pharma
US Senate committee accuses drug companies of ‘gaming’ the patent system | Industry representatives interrogated during hearing | ‘Playing games with patents has to stop’, says one Senator.   23 May 2024
Careers
The patent attorney’s expertise spans artificial intelligence, machine learning and medical devices.   23 May 2024
Biotechnology
New Jersey federal judge said Acuitas had failed to show case or controversy | Acuitas had sought declaratory judgment that Pfizer’s Comirnaty vaccine did not infringe patents.   23 May 2024